Gold nanoparticles capped with sulfate-ended ligands as anti-HIV agents

Bioorganic and Medicinal Chemistry Letters

Volumn 20, Issue 9, 2010, Pages 2718-2721

  Di Gianvincenzo, Paolo ^a   Marradi, Marco ^a   Martínez Ávila, Olga María ^a   Bedoya, Luis Miguel ^b   Alcamí, José ^b   Penadés, Soledad ^a  

^a BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Anti HIV systems; gp120 interaction; HIV neutralization assays; Sulfated gold nanoparticles; Surface plasmon resonance

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; GLYCOPROTEIN GP 120; GOLD NANOPARTICLE; SULFATE;

ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG COATING; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; LIGAND BINDING; NONHUMAN; SURFACE PLASMON RESONANCE; T LYMPHOCYTE;

ANTI-HIV AGENTS; CELL LINE; DRUG CARRIERS; GOLD; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HUMANS; LIGANDS; METAL NANOPARTICLES; SULFATES; SURFACE PLASMON RESONANCE;

EID: 77950858962     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bmcl.2010.03.079     Document Type: Article

References (23)

1. Kim J., Piao Y., and Hyeon T. Chem. Soc. Rev. 38 (2009) 372
2. De M., Ghosh P.S., and Rotello V.M. Adv. Mater. 20 (2008) 4225
3. Boisselier E., and Astruc D. Chem. Soc. Rev. 38 (2009) 1759
4. Rosi N.L., Giljohann D.A., Thaxton C.S., Lytton-Jean A.K.R., Han M.S., and Mirkin C.A. Science 312 (2006) 1027
5. Elechiguerra J.L., Burt J.L., Morones J.R., Camacho-Bragado A., Gao X., Lara H.H., and Yacaman M.J. J. Nanobiotechnol. 3 (2005) 6
6. Sun R.W.Y., Chen R., Chung N.P.Y., Ho C.M., Lin C.L.S., and Che C.M. Chem. Commun. (2005) 5059
7. Lu L., Sun R.W.Y., Chen R., Hui C.K., Ho C.M., Luk J.M., Lau G.K.K., and Che C.M. Antiviral Ther. 13 (2008) 253
8. Baram-Pinto D., Shukla S., Perkas N., Gedanken A., and Sarid R. Bioconjugate Chem. 20 (2009) 1497
9. Bowman M.C., Ballard T.E., Ackerson C.J., Feldheim D.L., Margolis D.M., and Melander C. J. Am. Chem. Soc. 130 (2008) 6896
10. Martínez-Ávila O., Bedoya L.M., Marradi M., Clavel C., Alcamí J., and Penadés S. Chembiochem 10 (2009) 1806
11. Witvrouw M., Desmyter J., and Declercq E. Antiviral Chem. Chemother. 5 (1994) 345
12. Scordi-Bello I.A., Mosoian A., He C.J., Chen Y.B., Cheng Y., Jarvis G.A., Keller M.J., Hogarty K., Waller D.P., Profy A.T., Herold B.C., and Klotman M.E. Antimicrob. Agents Chemother. 49 (2005) 3607
13. Balzarini J., and Van Damme L. Lancet 369 (2007) 787
14. Moulard M., Lortat-Jacob H., Mondor I., Roca G., Wyatt R., Sodroski J., Lu Z., Olson W., Kwong P.D., and Sattentau Q.J. J. Virol. 74 (2000) 1948
15. Fletcher P.S., Wallace G.S., Mesquita P.M.M., and Shattock R.J. Retrovirology (2006) 3
16. Gantlett K.E., Weber J.N., and Sattentau Q.J. Antiviral Res. 75 (2007) 188
17. Love J.C., Estroff L.A., Kriebel J.K., Nuzzo R.G., and Whitesides G.M. Chem. Rev. 105 (2005) 1103
18. Martinez-Avila O., Hijazi K., Marradi M., Clavel C., Campion C., Kelly C., and Penades S. Chem. Eur. J. 15 (2009) 9874
19. Guo L., Heinzinger N.K., Stevenson M., Schopfer L.M., and Salhany J.M. Antimicrob. Agents Chemother. 38 (1994) 2483
20. Cormier E.G., Persuh M., Thompson D.A.D., Lin S.W., Sakmar T.P., Olson W.C., and Dragic T. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 5762
21. Garcia-Perez J., Sanchez-Palomino S., Perez-Olmeda M., Fernandez B., and Alcami J. J. Med. Virol. 79 (2007) 127
22. Mammen M., Choi S.K., and Whitesides G.M. Angew. Chem., Int. Ed. 37 (1998) 2755
23. Balzarini J., Van Herrewege Y., Vermeire K., Vanham G., and Schols D. Mol. Pharmacol. 71 (2007) 3